T Araki

A novel therapeutic approach combining human plasma‐derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone

Y. Nakatomi, K. Tomokiyo, T. Nakagaki, 2003, Vox sanguinis.